Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of different doses of
bevacizumab injection in the treatment of malignant pleural effusion in patients with
advanced non-squamous non-small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Cancer Hospital
Collaborators:
Peking University First Hospital Peking University Third Hospital